You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for Silvergate Pharmaceuticals Inc. v. Bionpharma Inc. (D. Del. 2016)

✉ Email this page to a colleague

« Back to Dashboard

Silvergate Pharmaceuticals Inc. v. Bionpharma Inc. (D. Del. 2016)

Docket	⤷ Sign Up	Date Filed	2016-09-28
Court	District Court, D. Delaware	Date Terminated	2018-10-05
Cause	35:271 Patent Infringement	Assigned To	Mitchell S. Goldberg
Jury Demand	None	Referred To
Parties	BIONPHARMA INC.
Patents	6,028,222; 6,977,257; 7,758,890; 8,568,747; 8,685,460; 8,778,366; 9,855,214; 9,968,553
Attorneys	Anjali D. Deshmukh; Stephen R. Auten
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Small Molecule Drugs cited in Silvergate Pharmaceuticals Inc. v. Bionpharma Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Silvergate Pharmaceuticals Inc. v. Bionpharma Inc. (D. Del. 2016)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-01-16	147		pertaining to U.S. Patent Nos. 8,568,747 (the “’747 patent”) and 8,778,366 (the “’366 patent”) (collectively…matter of the Patents-in-Suit or any patents or patent applications related to the Patents-in-Suit ….” …Fed. Cir. 2007). The faces of the patents-in-suit, and the U.S. Patent and Trademark Office’s electronic… Production of Assignments and Licenses of the Patents-In-Suit - filed by Bionpharma Inc.. (Attachments… PRODUCTION OF ASSIGNMENTS AND LICENSES OF THE PATENTS-IN-SUIT Defendant Bionpharma Inc. (“Defendant	External link to document
2018-04-03	198		U.S. Patent No. 8,568,747 (“the ’747 Patent”) and U.S. Patent No. 8,778,366 (“the ’366 Patent”), has…include a third patent. While this patent will be litigated with the ’747 and the ’366 Patents, because claim…address only Column 19 of the ’747 Patent, the ’747 Patent and ’366 Patent share a common specification. I…of seven terms contained in the ’747 Patent and the ’366 Patent’s claims.2 1 On May 18, 2017, Chief… before the expiration of the ’747 Patent. The ’366 Patent was issued to the same inventors on	External link to document
2018-04-19	215		judgment of non-infringement of U.S. Patent Nos. 8,568,747 B2 and 8,778,366 B2 - re 214 Order,,. (Dorsney, …2016 5 October 2018 1:16-cv-00876 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.